DUBLIN--(BUSINESS WIRE)--The "Pharma Microbiology Testing Kits Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
The global pharma microbiology testing kits market is expected to grow from $5.12 billion in 2021 to $5.66 billion in 2022 at a compound annual growth rate (CAGR) of 10.7%. The market is expected to grow to $7.94 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%.
The rise in the incidence of infectious diseases is one of the prime drivers of the pharma microbiology testing kits market. According to CDC (Centre for Disease Control and Prevention), infectious diseases such as Hepatitis A, B, and C, sexually transmitted diseases (STDs), and human immunodeficiency virus (HIV) are increasing their prevalence globally.
A WHO report indicated that there were about 1.4 million cases of Hepatitis A reported globally every year. Hence the increasing number of infectious disease cases due to infected needle injections, unprotected sex, homelessness, lack of access to medical care, and other socioeconomic challenges drive the pharma microbiology testing kits market.
The limited shelf life of microorganisms and microbiology reagents acts as a major restraint on the pharma microbiology testing kits market. Shelf life is defined as the time for which a product remains fit for use after its generation. The shelf life of microbiology reagents depends upon exposure to atmospheric conditions.
The life of microorganisms such as bacteria (only 12 hours) is short therefore the time for microbiological research is very limited as the quality of microorganisms deteriorates and becomes unfit to use resulting in inaccurate pharma microbiology testing kits results. Hence, the short or limited shelf life of microbiology reagents may increase cost and hamper the pharma microbiology testing kits market growth.
Outsourcing of microbiological testing to contract testing laboratories is becoming popular in the pharma microbiology testing kits market. Outsourcing of routine microbiological testing activities controls and ensures better quality and safety of raw materials, intermediates, and finished products. The contract testing laboratories are outsourced with some testing areas such as stability testing, raw material testing, method validation, microbial testing, environmental monitoring, physical characterization, batch-release testing, bioanalytical testing, and others. For instance, the global healthcare analytical testing market is projected to expand to $4.13 billion by 2021 at a growth rate of 11.3%.
Food and Drug Administration (FDA) is a federal agency and regulatory body for the pharma microbiology testing kits market in the United States department of health and human services. Laboratories and food companies across the globe use these standards to make sure that food products are safe to eat and drink. FDA's Bacteriological Analytical Manual (BAM) detects pathogens (bacterial, viral, parasitic, plus yeast and mold) in food and cosmetic products. Enhanced standards for microbial testing, additional microbiological methods, and environmental testing methods have been set by FDA to ensure food and drug safety.
Scope
Markets Covered:
1) By Product: Consumables; Equipment
2) By Test: Endotoxin Testing; Sterility Testing; Microbial Examination; Environmental Monitoring; Other Tests
3) By End User: Hospitals & Diagnostic Centers; Custom Lab Service Providers; Academic & Research Institutes
Key Topics Covered:
1. Executive Summary
2. Pharma Microbiology Testing Kits Market Characteristics
3. Pharma Microbiology Testing Kits Market Trends And Strategies
4. Impact Of COVID-19 On Pharma Microbiology Testing Kits
5. Pharma Microbiology Testing Kits Market Size And Growth
6. Pharma Microbiology Testing Kits Market Segmentation
7. Pharma Microbiology Testing Kits Market Regional And Country Analysis
8. Asia-Pacific Pharma Microbiology Testing Kits Market
9. China Pharma Microbiology Testing Kits Market
10. India Pharma Microbiology Testing Kits Market
11. Japan Pharma Microbiology Testing Kits Market
12. Australia Pharma Microbiology Testing Kits Market
13. Indonesia Pharma Microbiology Testing Kits Market
14. South Korea Pharma Microbiology Testing Kits Market
15. Western Europe Pharma Microbiology Testing Kits Market
16. UK Pharma Microbiology Testing Kits Market
17. Germany Pharma Microbiology Testing Kits Market
18. France Pharma Microbiology Testing Kits Market
19. Eastern Europe Pharma Microbiology Testing Kits Market
20. Russia Pharma Microbiology Testing Kits Market
21. North America Pharma Microbiology Testing Kits Market
22. USA Pharma Microbiology Testing Kits Market
23. South America Pharma Microbiology Testing Kits Market
24. Brazil Pharma Microbiology Testing Kits Market
25. Middle East Pharma Microbiology Testing Kits Market
26. Africa Pharma Microbiology Testing Kits Market
27. Pharma Microbiology Testing Kits Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Pharma Microbiology Testing Kits Market
29. Pharma Microbiology Testing Kits Market Future Outlook and Potential Analysis
30. Appendix
Companies Mentioned
- F. Hoffmann-La Roche AG
- Becton Dickinson and Company
- Abbott Laboratories
- ThermoFisher Scientific
- Lucideon
- SGS SA
- ToxiKon
- Pace Analytical Services
- Boston Analytics
- Charles River Laboratories International
- Nelson Laboratories
- Siemens healthcare AG
- GenProbe
- Neogen Corporation
- Shimadzu Corporation
- Merck KGaA
- Agilent Technologies Inc.
- QIAGEN N.V.
- Hologic inc.
- Bruker Corporation
- bioMerieux SA
- Lucideon
For more information about this report visit https://www.researchandmarkets.com/r/d8q3h8
